ArticleAbdominal radiology (New York)2025
Radiomics-based automated machine learning for differentiating focal liver lesions on unenhanced computed tomography.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimsEnhanced computed tomography (CT) is the primary method for focal liver lesion diagnosis. We aimed to use automated machine learning (AutoML) algorithms to differentiate between benign and malignant focal liver lesions on the basis of radiomics from unenhanced CT images.
methodsWe enrolled 260 patients from 2 medical centers who underwent CT examinations between January 2017 and March 2023. This included 60 cases of hepatic malignancies, 93 cases of hepatic hemangiomas, 48 cases of hepatic abscesses, and 84 cases of hepatic cysts. The Pyradiomics method was used to extract radiomics features from unenhanced CT images. By using the mljar-supervised (MLJAR) AutoML framework, clinical, radiomics, and fusion models combining clinical and radiomics features were established.
resultsIn the training and validation sets, the area under the curve (AUC) values for the clinical, radiomics, and fusion models exceeded 0.900. In the external testing set, the respective AUC values for the clinical, radiomics, and fusion models were as follows: 0.88, 1.00, and 1.00 for hepatic cysts; 0.81, 0.90, and 0.97 for hepatic hemangiomas; 0.89, 0.98, and 0.92 for hepatic abscesses; and 0.23, 0.80, and 0.93 for hepatic malignancies. The diagnostic accuracy rates for hepatic cysts, hemangiomas, malignancies, and abscesses by radiologists in the external testing cohort were 0.96, 0.60, 0.79, and 0.66, respectively.
conclusionThe fusion model based on noninvasive radiomics and clinical features of unenhanced CT images has high clinical value for distinguishing focal hepatic lesions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.